Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau

KN Green, JS Steffan, H Martinez-Coria… - Journal of …, 2008 - Soc Neuroscience
Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or
delay its onset are urgently needed. Effective preventive strategies likely offer the greatest …

Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau

KN Green, JS Steffan, H Martinez-Coria, X Sun… - Journal of …, 2008 - hero.epa.gov
Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or
delay its onset are urgently needed. Effective preventive strategies likely offer the greatest …

Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau

KN Green, JS Steffan… - The Journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or
delay its onset are urgently needed. Effective preventive strategies likely offer the greatest …

[HTML][HTML] Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231 …

KN Green, JS Steffan, H Martinez-Coria… - The Journal of …, 2008 - ncbi.nlm.nih.gov
Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or
delay its onset are urgently needed. Effective preventive strategies likely offer the greatest …

[PDF][PDF] Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231 …

KN Green, JS Steffan, H Martinez-Coria… - The Journal of …, 2008 - Soc Neuroscience
Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or
delay its onset are urgently needed. Effective preventive strategies likely offer the greatest …

[引用][C] Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231 …

KN Green, JS Steffan, H Martinez-Coria, X Sun… - Journal of …, 2008 - cir.nii.ac.jp
Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism
Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau | CiNii Research …

[PDF][PDF] Nicotinamide restores cognition in AD transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau

KN Green, JS Steffan, H Martinez-Coria, X Sun… - J Neurosci, 2008 - researchgate.net
Memory loss is the signature feature of Alzheimer's disease and therapies that prevent or
delay its onset are urgently needed. Effective preventive strategies likely offer the greatest …

Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.

KN Green, JS Steffan, H Martinez-Coria… - The Journal of …, 2008 - europepmc.org
Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or
delay its onset are urgently needed. Effective preventive strategies likely offer the greatest …

[HTML][HTML] Nicotinamide restores cognition in AD transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau

KN Green, JS Steffan, H Martinez-Coria… - The Journal of …, 2008 - ncbi.nlm.nih.gov
Memory loss is the signature feature of Alzheimer's disease and therapies that prevent or
delay its onset are urgently needed. Effective preventive strategies likely offer the greatest …